Shopping Cart
- Remove All
- Your shopping cart is currently empty
Rislenemdaz (CERC-301) (CERC-301) is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $98 | In Stock | |
5 mg | $313 | In Stock | |
10 mg | $496 | In Stock | |
25 mg | $828 | In Stock | |
50 mg | $1,150 | In Stock | |
100 mg | $1,550 | In Stock | |
1 mL x 10 mM (in DMSO) | $345 | In Stock |
Description | Rislenemdaz (CERC-301) (CERC-301) is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B). |
Targets&IC50 | NMDAR 2B:3.6 nM, GluN2B:8.1 nM (ki), GluN2B:3.6 nM |
In vitro | rislemdaz (CERC-301) inhibited calcium influx in agonist stimulated NMDA-GluN1a/GluN2B L(tk-) cells. rislemdaz (CERC-301) had an IC50 of 3.6 nM. rislemdaz is highly selective for GluN2B receptors. rislemdaz showed minimal activity against sigma-type receptors at a concentration of 10 uM[1]. |
Alias | MK-0657, CERC-301 |
Molecular Weight | 358.41 |
Formula | C19H23FN4O2 |
Cas No. | 808732-98-1 |
Smiles | Cc1ccc(COC(=O)N2CC[C@H](CNc3ncccn3)[C@H](F)C2)cc1 |
Relative Density. | 1.24 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 90.0 mg/mL (251.1 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.